Patent details

LUC00262 Product Name: Ponésimod (nom IUPAC : (R)-5-[3-chloro-4-(2,3-dihydroxy-propoxy)-benz[Z]ylidene]-2-([Z]-propylimino)-3-o-tolyl-thiazolidin-4-one), et ses sels pharmaceutiquement acceptables

Basic Information

Publication number:
LUC00262
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP158079160
Legal Status:
Inactive
Application number:
LUC00262
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/21/1550
Marketing Authorization Type:
Marketing Authorization Date:
21/05/2021
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
13/05/2022
First Marketing Authorization date:
21/05/2021
Grant date:
25/04/2025
Activation date:
Publication date:
13/05/2022
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
21/05/2036
SPC Extension Expiration:
21/05/2036
Rejection date:
Withdrawal date:

Owner

From:
21/07/2025
 
 

Name:
Laboratoires Juvise Pharmaceuticals
Address:
149 boulevard Bataille de Stalingrad, 69100 Villeurbanne, France (FR)

History of Owners

From:
13/05/2022
To:
21/07/2025

Name:
Actelion Pharmaceuticals Ltd
Address:
Gewerbestrasse 16, 4123 Allschwil, Switzerland (CH)

Agent

1

Name:
Dennemeyer & Associates S.A.
From:
26/03/2025
Address:
55, rue des Bruyères, L-1274, HOWALD, Luxembourg (LU)
To:

2

Name:
OFFICE FREYLINGER S.A.
From:
13/05/2022
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:
25/03/2025

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2022/07
Publication date:
03/06/2022
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
SPC2
Bulletin edition number:
2025/06
Publication date:
12/05/2025
Description:
Section D : Granted supplementary protection certificates – I2 publication

3

Bulletin Heading:
CO
Bulletin edition number:
2025/09
Publication date:
05/08/2025
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20250000249A
Date Registered:
21/07/2025
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
Dennemeyer & Associates S.A.
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
Laboratoires Juvise Pharmaceuticals
Address:
149 boulevard Bataille de Stalingrad, 69100 Villeurbanne, France (FR)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
31/12/2035
Annual Fee Number:
21
Annual Fee Amount:
410 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
13/05/2022 Application Form 3
13/05/2022 Marketing authorization 3
13/05/2022 Summary of the product caracteristics 64
13/05/2022 MA publication 7
13/05/2022 Outgoing Correspondence 1
02/06/2022 Incoming Correspondence (Post) 1
02/06/2022 Outgoing Correspondence 1
25/04/2025 Outgoing Correspondence 1
13/05/2022 Publication 1
25/04/2025 Publication 1
25/04/2025 Certificate 1
25/03/2025 General Document 1
25/03/2025 General Document 1
25/03/2025 Outgoing Correspondence 2
25/03/2025 Incoming Correspondence (Email) 2
25/03/2025 Request For Change 1
26/03/2025 Outgoing Correspondence 1
26/03/2025 General Document 1
26/03/2025 Outgoing Correspondence 2
26/03/2025 Incoming Correspondence (Email) 2
26/03/2025 General Document 1
26/03/2025 Outgoing Correspondence 1
21/07/2025 Request For Change 35
30/07/2025 Outgoing Correspondence 1